If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Marketing Management » Marketing Teams: Structure, Staffing and Budgets
Download FREE Excerpt
14 Info Graphics
18 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Disease state awareness campaigns have long been used by the pharmaceutical industry to disseminate unbranded information to key external stakeholders, such as physicians and patients. Disease awareness campaigns are one of the few ways to reach patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch.
While some organizations effectively utilize disease awareness programs, others struggle to connect their campaigns to their targeted audiences. Best Practices, LLC conducted a primary research study that looked at issues such as when are companies first using disease awareness programs and when should you invest the most resources in disease awareness campaigns?
The study provides insights and benchmarks that illustrate how leading pharma and biotech companies are approaching issues of structure, timing and budget to ensure the effectiveness of their disease awareness program.
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Public Relations; Health Care; Biopharmaceutical
Bayer; Abbvie; Genzyme; Adamas Pharmaceuticals; AstraZeneca; Biogen; Novartis; Eli Lilly; FleishmanHillard; Fresenius Medical Care AG & Co. KGaA; ZS Pharma; Indivior; Merck; Catalyst Pharmaceuticals; Prometheus Therapeutics & Diagnostics; Tokai Pharmaceuticals; Vertex Pharmaceuticals